Cancers and COVID-19 Risk: A Mendelian Randomization Study

Observational studies have shown increased COVID-19 risk among cancer patients, but the causality has not been proven yet. Mendelian randomization analysis can use the genetic variants, independently of confounders, to obtain causal estimates which are considerably less confounded. We aimed to investigate the causal associations of cancers with COVID-19 outcomes using the MR analysis. The inverse-variance weighted (IVW) method was employed as the primary analysis. Sensitivity analyses and multivariable MR analyses were conducted. Notably, IVW analysis of univariable MR revealed that overall cancer and twelve site-specific cancers had no causal association with COVID-19 severity, hospitalization or susceptibility. The corresponding -values for the casual associations were all statistically insignificant: overall cancer ( = 0.34; = 0.42; = 0.69), lung cancer ( = 0.60; = 0.37; = 0.96), breast cancer ( = 0.43; = 0.74; = 0.43), endometrial cancer ( = 0.79; = 0.24; = 0.83), prostate cancer ( = 0.54; = 0.17; = 0.58), thyroid cancer ( = 0.70; = 0.80; = 0.28), ovarian cancer ( = 0.62; = 0.96; = 0.93), melanoma ( = 0.79; = 0.45; = 0.82), small bowel cancer ( = 0.09; = 0.08; = 0.19), colorectal cancer ( = 0.85; = 0.79; = 0.30), oropharyngeal cancer ( = 0.31; not applicable, NA; = 0.80), lymphoma ( = 0.51; NA; = 0.37) and cervical cancer ( = 0.25; = 0.32; = 0.68). Sensitivity analyses and multivariable MR analyses yielded similar results. In conclusion, cancers might have no causal effect on increasing COVID-19 risk. Further large-scale population studies are needed to validate our findings.